Pregled po CROSBI profilu: Marko Lucijanic (CROSBI Profil: 34517, MBZ: 365834, ORCID: 0000-0002-1372-2040, OBAD: -347024)

1.

Lucijanic, Marko; Veic, Petra; Aric, Ivona; Tupek, Katarina Marija; Soric, Ena; Sabljic, Anica; Vlasac Glasnovic, Josipa; Stoos-Veic, Tajana; Krecak, Ivan; Kusec, Rajko

Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time // Annals of Hematology (2023) doi:10.1007/s00277-023-05305-3 (međunarodna recenzija, online first)

doi

2.

Krečak, Ivan; Grohovac, Dragana; Vučenović Bašić, Nikolina; Čeko, Monika; Nižetić, Karla; Sabljić, Anica; Holik, Hrvoje; Galušić, Davor; Zekanović, Ivan; Morić Perić, Martina et al.

Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms // Thrombosis Research (2023) doi:10.1016/j.thromres.2023.03.004 (međunarodna recenzija, online first)

doi

3.

Krečak, Ivan; Zekanović, Ivan; Morić Perić, Martina; Holik, Hrvoje; Coha, Božena; Periša, Vlatka; Lucijanić, Marko

High plateletcrit may be associated with thrombotic risk in polycythemia vera // International Journal of Laboratory Hematology (2023) doi:10.1111/ijlh.14073 (međunarodna recenzija, online first)

doi

4.

Lucijanic, Marko; Marelic, Daniela; Stojic, Josip; Markovic, Ivan; Sedlic, Filip; Kralj, Ivan; Rucevic, Davor; Busic, Niksa; Javor, Patrik; Lucijanic, Tomo et al.

Predictors of prolonged hospitalization of COVID-19 patients // European Geriatric Medicine (2023) doi:10.1007/s41999-023-00787-w (međunarodna recenzija, online first)

doi

5.

Lucijanic, Marko; Krecak, Ivan

Pulmonary embolism, is it healthy to be volume expanded? // European Journal of Internal Medicine (2023) doi:10.1016/j.ejim.2023.05.010 (međunarodna recenzija, online first)

doi

6.

Lucijanic, Jelena; Hanzevacki, Miroslav; Bazdaric, Ksenija; Jurin, Ivana; Lucijanic, Marko

Vaccine uptake in caregivers family members and patients with dementia and relationship with severity of dementia and caregiver burden: a cross-sectional study // Aging Clinical and Experimental Research (2023) doi:10.1007/s40520-023-02443-6 (međunarodna recenzija, poslan)

doi

7.

Holik, Hrvoje; Lucijanic, Marko; Krecak, Ivan

Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease // Annals of Hematology (2023) doi:10.1007/s00277-023-05296-1 (međunarodna recenzija, online first)

doi

8.

Krečak, Ivan; Pivac, Ljerka; Lucijanić, Marko; Skelin, Marko

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms // Biomedicines, 11 (2023), 5; 1301, 16 doi:10.3390/biomedicines11051301 (međunarodna recenzija, članak, znanstveni)

doi

9.

Lucijanic, Marko; Krecak, Ivan

Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms // Journal of Thrombosis and Thrombolysis, 55 (2023), 4; 760-761 doi:10.1007/s11239-023-02779-w (međunarodna recenzija, članak, znanstveni)

doi

10.

Lucijanic, Marko; Bistrovic, Petra; Jordan, Ana; Mihaljevic, Iva; Bukvic, Stela; Kovacevic, Stjepan; Ranilovic, Darjan; Sakota, Sara; Vlasac Glasnovic, Josipa; Delic-Brkljacic, Diana

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events // The American Journal of Emergency Medicine, 70 (2023), 41-45 doi:10.1016/j.ajem.2023.05.007 (međunarodna recenzija, članak, znanstveni)

doi

11.

Krečak, Ivan; Čeko, Monika; Nižetić, Karla; Čubrić, Eva; Županović, Mediana; Skelin, Marko; Lucijanić, Marko

Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism // Scandinavian Journal of Clinical and Laboratory Investigation, 83 (2023), 3; 200-203 doi:10.1080/00365513.2023.2191334 (međunarodna recenzija, članak, znanstveni)

doi

12.

Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Sabljic, Anica; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Peric, Martina Moric; Zekanovic, Ivan; Kusec, Rajko

Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis // Biochemia Medica, 33 (2023), 2; 020901, 8 doi:10.11613/bm.2023.020901 (međunarodna recenzija, članak, znanstveni)

doi

13.

Lucijanić, Marko; Živković, Nevenka Piskač; Režić, Tanja; Durlen, Ivan; Stojić, Josip; Jurin, Ivana; Šakota, Sara; Filipović, Dora; Kurjaković, Iva; Jordan, Ana et al.

The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO Index, 4C Mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: data on 4014 patients from a tertiary center registry // Croatian Medical Journal, 64 (2023), 1; 13-20 doi:10.3325/cmj.2023.64.13 (međunarodna recenzija, članak, znanstveni)

doi

14.

Salai, Grgur; Vrazic, Hrvoje; Kovacevic, Ivona; Janes, Linda Malnar; Marasovic, Ivan; Ranilovic, Darjan; Vukoja, Damir; Zelenika Margeta, Marina; Huljev–Sipos, Ivana; Lalic, Kristina et al.

Investigating the role of obstructive pulmonary diseases and eosinophil count at admission on all- cause mortality in SARS-CoV-2 patients // Wiener klinische Wochenschrift, (2023), 2023 Apr 24; 1-9 doi:10.1007/s00508-023-02180-w (međunarodna recenzija, članak, znanstveni)

Pristup cjelovitom tekstu rada doi pubmed.ncbi.nlm.nih.gov link.springer.com

15.

Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, Rajko

Palpable spleen size is differently prognostic in primary and secondary myelofibrosis // Leukemia & lymphoma, 64 (2023), 4; 893-896 doi:10.1080/10428194.2023.2179360 (međunarodna recenzija, pismo, znanstveni)

doi www.tandfonline.com

16.

Bistrovic, Petra; Sabljic, Anica; Kovacevic, Ivona; Cikara, Tomislav; Keres, Tatjana; Lucijanic, Tomo; Mitrovic, Josko; Delic- Brkljacic, Diana; Manola, Sime; Lucijanic, Marko

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre // International Journal of Cardiology, 372 (2023), 144-149 doi:10.1016/j.ijcard.2022.11.051 (međunarodna recenzija, članak, znanstveni)

doi

17.

Krečak, Ivan; Lucijanić, Marko

Can we use platelet-to-lymphocyte ratio (PLR) to differentiate JAK2-unmutated erythrocytosis from polycythemia vera? // European journal of internal medicine, 108 (2023), 120-121 doi:10.1016/j.ejim.2022.09.023 (međunarodna recenzija, pismo, znanstveni)

doi

18.

Lucijanić, M.; Bistrović, P.; Papić, I.; Ortner Hadžiabdić, M.

Klinička iskustva primjene remdesivira // Knjiga sažetaka 3. hrvatskog kongresa kliničke farmacije / Ortner Hadžiabdić, M. (ur.).
Zagreb: Hrvatsko farmaceutsko društvo, 2022. str. 40-40 (poster, domaća recenzija, sažetak, znanstveni)

19.

Periša, Vlatka; Lucijanić, Marko; Mrđenović, Stefan; Laslo, Dorian

The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel prognostic factor for patients with diffuse large B-cell lymphoma // Journal of Cancer Research and Therapeutics, 18 (2022), 3; 725-732 doi:10.4103/jcrt.jcrt_174_21 (međunarodna recenzija, članak, znanstveni)

doi

20.

Hasselbalch, Hans; Skov, Vibe; Kjær, Lasse; Larsen, Morten Kranker; Knudsen, Trine A.; Lucijanić, Marko; Kušec, Rajko

Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives // Cancers, 14 (2022), 22; 5495, 14 doi:10.3390/cancers14225495 (međunarodna recenzija, članak, znanstveni)

doi

21.

Krečak, Ivan; Sabljić, Anica; Lucijanić, Marko

Understanding and modifying thrombotic risk in patients with myeloproliferative neoplasms // Journal of Cardiology, 81 (2022), 6; 586-586 doi:10.1016/j.jjcc.2022.12.009 (međunarodna recenzija, pismo uredniku, znanstveni)

doi www.sciencedirect.com

22.

Krečak, Ivan; Nižetić, Karla; Čeko, Monika; Skelin, Marko; Lucijanić, Marko

Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism // International journal of laboratory hematology, 45 (2022), 2; e32-e35 doi:10.1111/ijlh.13982 (međunarodna recenzija, pismo uredniku, znanstveni)

doi onlinelibrary.wiley.com

23.

Krečak, Ivan; Holik, Hrvoje; Morić Perić, Martina; Zekanović, Ivan; Coha, Božena; Lucijanić, Marko

Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case–Control Analysis // Indian Journal of Hematology and Blood Transfusion (2022) doi:10.1007/s12288-022-01624-z (međunarodna recenzija, online first)

doi

24.

Jurin, Ivana; Lucijanić, Marko; Piskač Živković, Nevenka; Lalić, Kristina; Zrilić Vrkljan, Anamarija; Malnar Janeš, Linda; Kovačević, Ivona; Čikara, Tomislav; Sabljić, Anica; Bušić, Nikolina et al.

Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a tertiary center registry // Croatian medical journal, 63 (2022), 1; 16-26 doi:10.3325/cmj.2022.63.16 (međunarodna recenzija, članak, znanstveni)

doi www.cmj.hr

25.

Piskač Živković, Nevenka; Lucijanić, Marko; Bušić, Nikolina; Jurin, Ivana; Atić, Armin; Andrilović, Ana; Penović, Toni; Domić, Iva; Gnjidić, Jelena; Demaria, Martina et al.

The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry // Croatian medical journal, 63 (2022), 1; 36-43 doi:10.3325/cmj.2022.63.36 (međunarodna recenzija, članak, znanstveni)

doi www.ncbi.nlm.nih.gov